[
  {
    "title": "SearchSearchShareShareFacebookTwitterLinkedInMailLocationLocationNorth AmericaEuropeAsiaIdorsia is expanding its global footprint to reach more patien",
    "link": "https://www.idorsia.com/",
    "timestamp": "unknown"
  },
  {
    "title": "SearchSearchShareShareFacebookTwitterLinkedInMailLocationLocationNorth AmericaEuropeAsiaIdorsia is expanding its global footprint to reach more patien",
    "link": "https://www.idorsia.com/",
    "timestamp": "unknown"
  },
  {
    "title": "SearchSearchShareShareFacebookTwitterLinkedInMailLocationLocationNorth AmericaEuropeAsiaIdorsia is expanding its global footprint to reach more patien",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "SearchSearch",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "ShareShareFacebookTwitterLinkedInMail",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "ShareFacebookTwitterLinkedInMail",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "FacebookTwitterLinkedInMail",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "FacebookTwitterLinkedInMail",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "FacebookTwitterLinkedInMail",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "FacebookTwitterLinkedInMail",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "Facebook",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "Twitter",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "LinkedIn",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "Mail",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "LocationLocationNorth AmericaEuropeAsiaIdorsia is expanding its global footprint to reach more patients with our transformative treatments.We conduct ",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "LocationNorth AmericaEuropeAsiaIdorsia is expanding its global footprint to reach more patients with our transformative treatments.We conduct research",
    "link": "https://www.idorsia.com",
    "timestamp": "unknown"
  },
  {
    "title": "North AmericaEuropeAsiaIdorsia is expanding its global footprint to reach more patients with our transformative treatments.We conduct research, clinic",
    "link": "https://www.idorsia.com",
    "timestamp": "unknown"
  },
  {
    "title": "North AmericaEuropeAsiaIdorsia is expanding its global footprint to reach more patients with our transformative treatments.We conduct research, clinic",
    "link": "https://www.idorsia.com",
    "timestamp": "unknown"
  },
  {
    "title": "North AmericaEuropeAsiaIdorsia is expanding its global footprint to reach more patients with our transformative treatments.We conduct research, clinic",
    "link": "https://www.idorsia.com",
    "timestamp": "unknown"
  },
  {
    "title": "North AmericaEuropeAsiaIdorsia is expanding its global footprint to reach more patients with our transformative treatments.We conduct research, clinic",
    "link": "https://www.idorsia.com",
    "timestamp": "unknown"
  },
  {
    "title": "AustriaAllschwil,SwitzerlandBerlin, GermanyCherry Hill, New Jersey, USAL\u00f6rrach,GermanyLondon,UKMadrid, SpainMontreal, CanadaMunich,GermanyParis, Franc",
    "link": "https://www.idorsia.com",
    "timestamp": "unknown"
  },
  {
    "title": "Idorsia Pharmaceuticals LtdHegenheimermattweg 914123 AllschwilSwitzerlandHeadquarters of Idorsia Ltd.Responsible for drug discovery, development, regi",
    "link": "https://www.idorsia.com",
    "timestamp": "unknown"
  },
  {
    "title": "www.idorsia.comContact us online",
    "link": "https://www.idorsia.com",
    "timestamp": "unknown"
  },
  {
    "title": "www.idorsia.com",
    "link": "https://www.idorsia.com",
    "timestamp": "unknown"
  },
  {
    "title": "Contact us online",
    "link": "https://www./contact/general-enquiries.html",
    "timestamp": "unknown"
  },
  {
    "title": "ContactContactGeneral ContactGeneral Contact:Idorsia Pharmaceuticals LtdHegenheimermattweg 914123 AllschwilSwitzerland+41 58 844 00 00Please get in to",
    "link": "https://www.idorsia.com/media/news/news-archive?page=1&limit=20",
    "timestamp": "unknown"
  },
  {
    "title": "HomeAbout IdorsiaAbout IdorsiaOverviewOur strategic prioritiesOur PeoplePartnershipsHow we startedOur InnovationOur InnovationOverviewServing patients",
    "link": "https://www.idorsia.com/",
    "timestamp": "unknown"
  },
  {
    "title": "HomeAbout IdorsiaAbout IdorsiaOverviewOur strategic prioritiesOur PeoplePartnershipsHow we startedOur InnovationOur InnovationOverviewServing patients",
    "link": "https://www.idorsia.com/",
    "timestamp": "unknown"
  },
  {
    "title": "HomeAbout IdorsiaAbout IdorsiaOverviewOur strategic prioritiesOur PeoplePartnershipsHow we startedOur InnovationOur InnovationOverviewServing patients",
    "link": "https://www.idorsia.com/",
    "timestamp": "unknown"
  },
  {
    "title": "HomeAbout IdorsiaAbout IdorsiaOverviewOur strategic prioritiesOur PeoplePartnershipsHow we startedOur InnovationOur InnovationOverviewServing patients",
    "link": "https://www.idorsia.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Home",
    "link": "https://www.idorsia.com/",
    "timestamp": "unknown"
  },
  {
    "title": "About IdorsiaAbout IdorsiaOverviewOur strategic prioritiesOur PeoplePartnershipsHow we started",
    "link": "https://www.idorsia.com/about-idorsia.html",
    "timestamp": "unknown"
  },
  {
    "title": "Our strategic priorities",
    "link": "https://www.idorsia.com/about-idorsia/strategic-priorities.html",
    "timestamp": "unknown"
  },
  {
    "title": "Our People",
    "link": "https://www.idorsia.com/about-idorsia/our-people.html",
    "timestamp": "unknown"
  },
  {
    "title": "Partnerships",
    "link": "https://www.idorsia.com/about-idorsia/partnerships.html",
    "timestamp": "unknown"
  },
  {
    "title": "How we started",
    "link": "https://www.idorsia.com/about-idorsia/how-we-started.html",
    "timestamp": "unknown"
  },
  {
    "title": "Our InnovationOur InnovationOverviewServing patientsBench to BedsideAprocitentan videosPortfolioPortfolioPortfolio overviewDaridorexantAprocitentanLuc",
    "link": "https://www.idorsia.com/our-innovation.html",
    "timestamp": "unknown"
  },
  {
    "title": "Serving patients",
    "link": "https://www.idorsia.com/our-innovation/serving-patients.html",
    "timestamp": "unknown"
  },
  {
    "title": "Bench to Bedside",
    "link": "https://www.idorsia.com/our-innovation/bench-to-bedside.html",
    "timestamp": "unknown"
  },
  {
    "title": "Aprocitentan videos",
    "link": "https://www.idorsia.com/our-innovation/aprocitentan-videos.html",
    "timestamp": "unknown"
  },
  {
    "title": "PortfolioPortfolioPortfolio overviewDaridorexantAprocitentanLucerastat",
    "link": "https://www.idorsia.com/our-innovation/portfolio.html",
    "timestamp": "unknown"
  },
  {
    "title": "Portfolio overview",
    "link": "https://www.idorsia.com/our-innovation/portfolio/portfolio-overview.html",
    "timestamp": "unknown"
  },
  {
    "title": "Daridorexant",
    "link": "https://www.idorsia.com/our-innovation/portfolio/daridorexant.html",
    "timestamp": "unknown"
  },
  {
    "title": "Aprocitentan",
    "link": "https://www.idorsia.com/our-innovation/portfolio/aprocitentan.html",
    "timestamp": "unknown"
  },
  {
    "title": "Lucerastat",
    "link": "https://www.idorsia.com/our-innovation/portfolio/lucerastat.html",
    "timestamp": "unknown"
  },
  {
    "title": "Target DiseasesTarget DiseasesInsomniaHypertensionFabry disease",
    "link": "https://www.idorsia.com/our-innovation/target-diseases.html",
    "timestamp": "unknown"
  },
  {
    "title": "Insomnia",
    "link": "https://www.idorsia.com/our-innovation/target-diseases/insomnia.html",
    "timestamp": "unknown"
  },
  {
    "title": "Hypertension",
    "link": "https://www.idorsia.com/our-innovation/target-diseases/hypertension.html",
    "timestamp": "unknown"
  },
  {
    "title": "Fabry disease",
    "link": "https://www.idorsia.com/our-innovation/target-diseases/fabry-disease.html",
    "timestamp": "unknown"
  },
  {
    "title": "SustainabilitySustainabilityOverviewOur ApproachAdvancing science and healthcarePeople and societyEnvironmentCompliance and business ethicsReporting",
    "link": "https://www.idorsia.com/sustainability.html",
    "timestamp": "unknown"
  },
  {
    "title": "Our Approach",
    "link": "https://www.idorsia.com/sustainability/our-approach.html",
    "timestamp": "unknown"
  },
  {
    "title": "Advancing science and healthcare",
    "link": "https://www.idorsia.com/sustainability/advancing-science-healthcare.html",
    "timestamp": "unknown"
  },
  {
    "title": "People and society",
    "link": "https://www.idorsia.com/sustainability/people-society.html",
    "timestamp": "unknown"
  },
  {
    "title": "Environment",
    "link": "https://www.idorsia.com/sustainability/environment.html",
    "timestamp": "unknown"
  },
  {
    "title": "Compliance and business ethics",
    "link": "https://www.idorsia.com/sustainability/compliance-business-ethics.html",
    "timestamp": "unknown"
  },
  {
    "title": "Reporting",
    "link": "https://www.idorsia.com/sustainability/reporting.html",
    "timestamp": "unknown"
  },
  {
    "title": "InvestorsInvestorsOverviewResults Day CenterEquity storyFinancial InformationCorporate ReportsNews & EventsNews & EventsMedia releasesInvestor webcast",
    "link": "https://www.idorsia.com/investors.html",
    "timestamp": "unknown"
  },
  {
    "title": "Results Day Center",
    "link": "https://www.idorsia.com/investors/results-day-center.html",
    "timestamp": "unknown"
  },
  {
    "title": "Equity story",
    "link": "https://www.idorsia.com/investors/equity-story.html",
    "timestamp": "unknown"
  },
  {
    "title": "Financial Information",
    "link": "https://www.idorsia.com/investors/financial-information.html",
    "timestamp": "unknown"
  },
  {
    "title": "Corporate Reports",
    "link": "https://www.idorsia.com/investors/corporate-reports.html",
    "timestamp": "unknown"
  },
  {
    "title": "News & EventsNews & EventsMedia releasesInvestor webcastsAnnual General Meeting",
    "link": "https://www.idorsia.com/investors/news-and-events.html",
    "timestamp": "unknown"
  },
  {
    "title": "Media releases",
    "link": "https://www.idorsia.com/investors/news-and-events/media-releases.html",
    "timestamp": "unknown"
  },
  {
    "title": "Investor webcasts",
    "link": "https://www.idorsia.com/investors/news-and-events/investor-webcasts.html",
    "timestamp": "unknown"
  },
  {
    "title": "Annual General Meeting",
    "link": "https://www.idorsia.com/investors/news-and-events/annual-general-meeting.html",
    "timestamp": "unknown"
  },
  {
    "title": "Stock informationStock informationStock overviewStock chart toolsConsensus Estimates",
    "link": "https://www.idorsia.com/investors/stock-information.html",
    "timestamp": "unknown"
  },
  {
    "title": "Stock overview",
    "link": "https://www.idorsia.com/investors/stock-information/stock-overview.html",
    "timestamp": "unknown"
  },
  {
    "title": "Stock chart tools",
    "link": "https://www.idorsia.com/investors/stock-information/stock-chart-tools.html",
    "timestamp": "unknown"
  },
  {
    "title": "Consensus Estimates",
    "link": "https://www.idorsia.com/investors/stock-information/consensus-estimate.html",
    "timestamp": "unknown"
  },
  {
    "title": "Governance",
    "link": "https://www.idorsia.com/investors/governance.html",
    "timestamp": "unknown"
  },
  {
    "title": "Restricted InvestorRestricted InvestorRestricted AccessRestricted DisclaimerDisclaimer Exchange OfferRestricted DeclineRestricted ContentExchange Offe",
    "link": "https://www.idorsia.com/investors/restricted.html",
    "timestamp": "unknown"
  },
  {
    "title": "Restricted Access",
    "link": "https://www.idorsia.com/investors/restricted/access.html",
    "timestamp": "unknown"
  },
  {
    "title": "Restricted Disclaimer",
    "link": "https://www.idorsia.com/investors/restricted/disclaimer.html",
    "timestamp": "unknown"
  },
  {
    "title": "Disclaimer Exchange Offer",
    "link": "https://www.idorsia.com/investors/restricted/disclaimer-exo.html",
    "timestamp": "unknown"
  },
  {
    "title": "Restricted Decline",
    "link": "https://www.idorsia.com/investors/restricted/decline.html",
    "timestamp": "unknown"
  },
  {
    "title": "Restricted Content",
    "link": "https://www.idorsia.com/investors/restricted/restricted-content-page.html",
    "timestamp": "unknown"
  },
  {
    "title": "Exchange Offer",
    "link": "https://www.idorsia.com/investors/restricted/exchange-offer.html",
    "timestamp": "unknown"
  },
  {
    "title": "MediaMediaOverviewNewsNewsNews archiveNews in GermanMedia centerSocial media",
    "link": "https://www.idorsia.com/media.html",
    "timestamp": "unknown"
  },
  {
    "title": "NewsNewsNews archiveNews in German",
    "link": "https://www.idorsia.com/media/news.html",
    "timestamp": "unknown"
  },
  {
    "title": "News archive",
    "link": "https://www.idorsia.com/media/news/news-archive.html",
    "timestamp": "unknown"
  },
  {
    "title": "News in German",
    "link": "https://www.idorsia.com/media/news/news-in-german.html",
    "timestamp": "unknown"
  },
  {
    "title": "Media center",
    "link": "https://www.idorsia.com/media/media-center.html",
    "timestamp": "unknown"
  },
  {
    "title": "Social media",
    "link": "https://www.idorsia.com/media/social-media.html",
    "timestamp": "unknown"
  },
  {
    "title": "CareersCareersOverviewWorking@IdorsiaJob opportunitiesLiving in BaselFAQ",
    "link": "https://www.idorsia.com/careers.html",
    "timestamp": "unknown"
  },
  {
    "title": "Working@Idorsia",
    "link": "https://www.idorsia.com/careers/working-at-idorsia.html",
    "timestamp": "unknown"
  },
  {
    "title": "Job opportunities",
    "link": "https://www.idorsia.com/careers/job-opportunities.html",
    "timestamp": "unknown"
  },
  {
    "title": "Living in Basel",
    "link": "https://www.idorsia.com/careers/living-in-basel.html",
    "timestamp": "unknown"
  },
  {
    "title": "FAQ",
    "link": "https://www.idorsia.com/careers/faq.html",
    "timestamp": "unknown"
  },
  {
    "title": "NewsNewsNews archiveMedia centerSocial media",
    "link": "https://www.idorsia.com/media/news.html",
    "timestamp": "unknown"
  },
  {
    "title": "NewsNewsNews archiveMedia centerSocial media",
    "link": "https://www.idorsia.com/media/news.html",
    "timestamp": "unknown"
  },
  {
    "title": "NewsNewsNews archive",
    "link": "https://www.idorsia.com/media/news.html",
    "timestamp": "unknown"
  },
  {
    "title": "NewsNews archive",
    "link": "https://www.idorsia.com/media/news/news-archive.html",
    "timestamp": "unknown"
  },
  {
    "title": "NewsNews archive",
    "link": "https://www.idorsia.com/media/news/news-archive.html",
    "timestamp": "unknown"
  },
  {
    "title": "News archive",
    "link": "https://www.idorsia.com/media/news/news-archive.html",
    "timestamp": "unknown"
  },
  {
    "title": "Media center",
    "link": "https://www.idorsia.com/media/media-center.html",
    "timestamp": "unknown"
  },
  {
    "title": "Social media",
    "link": "https://www.idorsia.com/media/social-media.html",
    "timestamp": "unknown"
  },
  {
    "title": "Media releasesGOAllAd hocOther23 Jul 2025Invitation to Idorsia's HY 2025 Financial Reporting webcast and conference call with our new CEO Srishti Gupt",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=",
    "timestamp": "unknown"
  },
  {
    "title": "Media releasesGOAllAd hocOther23 Jul 2025Invitation to Idorsia's HY 2025 Financial Reporting webcast and conference call with our new CEO Srishti Gupt",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=",
    "timestamp": "unknown"
  },
  {
    "title": "Media releasesGOAllAd hocOther23 Jul 2025Invitation to Idorsia's HY 2025 Financial Reporting webcast and conference call with our new CEO Srishti Gupt",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=",
    "timestamp": "unknown"
  },
  {
    "title": "Media releasesGOAllAd hocOther23 Jul 2025Invitation to Idorsia's HY 2025 Financial Reporting webcast and conference call with our new CEO Srishti Gupt",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=",
    "timestamp": "unknown"
  },
  {
    "title": "Media releasesGOAllAd hocOther23 Jul 2025Invitation to Idorsia's HY 2025 Financial Reporting webcast and conference call with our new CEO Srishti Gupt",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=",
    "timestamp": "unknown"
  },
  {
    "title": "GOAllAd hocOther23 Jul 2025Invitation to Idorsia's HY 2025 Financial Reporting webcast and conference call with our new CEO Srishti Gupta30 Jun 2025A ",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=",
    "timestamp": "unknown"
  },
  {
    "title": "AllAd hocOther",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=",
    "timestamp": "unknown"
  },
  {
    "title": "AllAd hocOther",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=",
    "timestamp": "unknown"
  },
  {
    "title": "All",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=ADHOC",
    "timestamp": "unknown"
  },
  {
    "title": "Other",
    "link": "https://www.idorsia.com/media/news/news-archive?language=en&filter=OTHERS",
    "timestamp": "unknown"
  },
  {
    "title": "23 Jul 2025Invitation to Idorsia's HY 2025 Financial Reporting webcast and conference call with our new CEO Srishti Gupta",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3495227",
    "timestamp": "unknown"
  },
  {
    "title": "23 Jul 2025Invitation to Idorsia's HY 2025 Financial Reporting webcast and conference call with our new CEO Srishti Gupta",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3495227",
    "timestamp": "unknown"
  },
  {
    "title": "30 Jun 2025A factory in a lab: Idorsia's breakthrough synthetic glycan vaccine platform validated for the first time in humans",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3480510",
    "timestamp": "unknown"
  },
  {
    "title": "30 Jun 2025A factory in a lab: Idorsia's breakthrough synthetic glycan vaccine platform validated for the first time in humans",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3480510",
    "timestamp": "unknown"
  },
  {
    "title": "25 Jun 2025Bondholders approve amended terms of the 2025 and 2028 convertible bonds",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3478556",
    "timestamp": "unknown"
  },
  {
    "title": "25 Jun 2025Bondholders approve amended terms of the 2025 and 2028 convertible bonds",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3478556",
    "timestamp": "unknown"
  },
  {
    "title": "25 Jun 2025Idorsia launches repurchase offer for its 2025 and 2028 convertible bonds",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3477937",
    "timestamp": "unknown"
  },
  {
    "title": "25 Jun 2025Idorsia launches repurchase offer for its 2025 and 2028 convertible bonds",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3477937",
    "timestamp": "unknown"
  },
  {
    "title": "23 Jun 2025Idorsia\u2019s QUVIVIQ expands into China as Simcere receives NDA approval \u2013 Idorsia and Simcere update their licensing agreement",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3476061",
    "timestamp": "unknown"
  },
  {
    "title": "23 Jun 2025Idorsia\u2019s QUVIVIQ expands into China as Simcere receives NDA approval \u2013 Idorsia and Simcere update their licensing agreement",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3476061",
    "timestamp": "unknown"
  },
  {
    "title": "10 Jun 2025Idorsia announces the appointment of Srishti Gupta, MD as CEO to ensure the long-term success of Idorsia",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3468377",
    "timestamp": "unknown"
  },
  {
    "title": "10 Jun 2025Idorsia announces the appointment of Srishti Gupta, MD as CEO to ensure the long-term success of Idorsia",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3468377",
    "timestamp": "unknown"
  },
  {
    "title": "06 Jun 2025Idorsia publishes invitations to bondholder meetings",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3466803",
    "timestamp": "unknown"
  },
  {
    "title": "06 Jun 2025Idorsia publishes invitations to bondholder meetings",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3466803",
    "timestamp": "unknown"
  },
  {
    "title": "28 May 2025Shareholders vote in favor of all proposals by the Board at Idorsia\u2019s Annual General Meeting 2025",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3460592",
    "timestamp": "unknown"
  },
  {
    "title": "28 May 2025Shareholders vote in favor of all proposals by the Board at Idorsia\u2019s Annual General Meeting 2025",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3460592",
    "timestamp": "unknown"
  },
  {
    "title": "21 May 2025New funds secured \u2013 allowing the commercial ramp-up of QUVIVIQ to accelerate Idorsia\u2019s path to profitability",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3456188",
    "timestamp": "unknown"
  },
  {
    "title": "21 May 2025New funds secured \u2013 allowing the commercial ramp-up of QUVIVIQ to accelerate Idorsia\u2019s path to profitability",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3456188",
    "timestamp": "unknown"
  },
  {
    "title": "02 May 2025Idorsia issues invitation to the 2025 Annual General Meeting of Shareholders",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3442503",
    "timestamp": "unknown"
  },
  {
    "title": "02 May 2025Idorsia issues invitation to the 2025 Annual General Meeting of Shareholders",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3442503",
    "timestamp": "unknown"
  },
  {
    "title": "30 Apr 2025Idorsia announces financial results for the first quarter 2025 \u2013 QUVIVIQ taking off in Europe and TRYVIO REMS removal increases the value o",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3440206",
    "timestamp": "unknown"
  },
  {
    "title": "30 Apr 2025Idorsia announces financial results for the first quarter 2025 \u2013 QUVIVIQ taking off in Europe and TRYVIO REMS removal increases the value o",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3440206",
    "timestamp": "unknown"
  },
  {
    "title": "29 Apr 2025New data with daridorexant assessing the transition from night to day in insomnia disorder published in Sleep Medicine",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3438936",
    "timestamp": "unknown"
  },
  {
    "title": "29 Apr 2025New data with daridorexant assessing the transition from night to day in insomnia disorder published in Sleep Medicine",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3438936",
    "timestamp": "unknown"
  },
  {
    "title": "16 Apr 2025Higher cantonal composition authority approved the amendments to the terms of the 2025 convertible bond",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3430660",
    "timestamp": "unknown"
  },
  {
    "title": "16 Apr 2025Higher cantonal composition authority approved the amendments to the terms of the 2025 convertible bond",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3430660",
    "timestamp": "unknown"
  },
  {
    "title": "09 Apr 2025The effect of aprocitentan for reducing blood pressure and proteinuria in Black patients with resistant hypertension published in Hypertens",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3426106",
    "timestamp": "unknown"
  },
  {
    "title": "09 Apr 2025The effect of aprocitentan for reducing blood pressure and proteinuria in Black patients with resistant hypertension published in Hypertens",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3426106",
    "timestamp": "unknown"
  },
  {
    "title": "09 Apr 2025US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirement",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3426097",
    "timestamp": "unknown"
  },
  {
    "title": "09 Apr 2025US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirement",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3426097",
    "timestamp": "unknown"
  },
  {
    "title": "27 Mar 2025Idorsia publishes its Annual Report 2024",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3417376",
    "timestamp": "unknown"
  },
  {
    "title": "27 Mar 2025Idorsia publishes its Annual Report 2024",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3417376",
    "timestamp": "unknown"
  },
  {
    "title": "17 Mar 2025US FDA removes REMS requirement for TRYVIO (aprocitentan) \u2013 minimizing the burden on the healthcare delivery systems and patients",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3409783",
    "timestamp": "unknown"
  },
  {
    "title": "17 Mar 2025US FDA removes REMS requirement for TRYVIO (aprocitentan) \u2013 minimizing the burden on the healthcare delivery systems and patients",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3409783",
    "timestamp": "unknown"
  },
  {
    "title": "14 Mar 2025Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3409056",
    "timestamp": "unknown"
  },
  {
    "title": "14 Mar 2025Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3409056",
    "timestamp": "unknown"
  },
  {
    "title": "04 Mar 2025Idorsia announces financial results for 2024",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3401710",
    "timestamp": "unknown"
  },
  {
    "title": "04 Mar 2025Idorsia announces financial results for 2024",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3401710",
    "timestamp": "unknown"
  },
  {
    "title": "26 Feb 2025Idorsia reaches an agreement with significant bondholders to restructure its convertible bond debt and to secure funding for future operati",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3397650",
    "timestamp": "unknown"
  },
  {
    "title": "26 Feb 2025Idorsia reaches an agreement with significant bondholders to restructure its convertible bond debt and to secure funding for future operati",
    "link": "https://www.idorsia.com/media/news/news-archive/media-release-details?id=3397650",
    "timestamp": "unknown"
  },
  {
    "title": "1",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=1&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "2",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=2&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "3",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=3&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "4",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=4&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "5",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=5&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "6",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=6&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "7",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=7&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "8",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=8&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "9",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=9&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "10",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=10&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "11",
    "link": "https://www.idorsia.com/media/news/news-archive.html?page=11&limit=20&filter=&language=en",
    "timestamp": "unknown"
  },
  {
    "title": "This website is subject to the terms and conditions outlined in the legal and privacy statement.Terms and conditionsPrivacy PolicyData NoticeSite mapC",
    "link": "https://www.facebook.com/idorsia/",
    "timestamp": "unknown"
  },
  {
    "title": "This website is subject to the terms and conditions outlined in the legal and privacy statement.",
    "link": "https://www.facebook.com/idorsia/",
    "timestamp": "unknown"
  },
  {
    "title": "Terms and conditionsPrivacy PolicyData NoticeSite mapCopyright \u00a9  2025 Idorsia Pharmaceuticals Ltd",
    "link": "https://www.idorsia.com/legal/terms-and-conditions",
    "timestamp": "unknown"
  },
  {
    "title": "Terms and conditionsPrivacy PolicyData NoticeSite map",
    "link": "https://www.idorsia.com/legal/terms-and-conditions",
    "timestamp": "unknown"
  }
]